Continuous Assessment of Brain Blood Perfusion in Subarachnoid Hemorrhage Patients Using Near-Infrared Spectroscopy (NIRS)

Not yet recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

December 31, 2028

Conditions
Subarachnoid Hemorrhage, Aneurysmal
Interventions
DEVICE

- Non-Invasive Near-infrared Spectroscopy (NIRS) device (HEM1 with Foresight Elite Sensor)

Near-Infrared Spectroscopy (NIRS) monitors, provided by Edwards Lifesciences, is a monitoring technique. It will be connected to consented patients, automatically capturing brain oxygen as waveform output, and stored in Sickbay system. The NIRS is a non-invasive monitoring method, in which adhesive pads will be applied to forehead. 4 hours continuous monitoring will be recorded on day 1 after SAH (or on presence to NICU), then every three days from day 3 to day 14 (within the DCI window), to 1 to 2 recordings from day 15 to day 21.

Trial Locations (1)

35294

The University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Edwards Lifesciences

INDUSTRY

lead

University of Alabama at Birmingham

OTHER